The Houston Fire Department Teams with ZOLL Medical Corporation to Provide Life-Saving Technology to Houstonians
Mayor Annise Parker has joined Houston Fire Department (HFD) Chief
Terry Garrison, Emergency Medical Services Director David Persse, M.D.,
and ZOLL Medical Corporation President Jonathan Rennert to announce a
partnership that will provide HFD firefighters with use of the ZOLL
AutoPulse® Non-Invasive Cardiac Support Pump.
The AutoPulse is an advanced life-saving device that provides
consistent, high-quality chest compressions and hands-free support that
saves critical seconds when paramedics and EMTs are resuscitating
victims of sudden cardiac arrest (SCA). The devices, accessories, and
training, worth an estimated $3.8 million, will be provided at no cost
to the city.
HFD emergency personnel performed outstandingly in an international
randomized clinical trial in which preliminary indications demonstrate
that the automated CPR device performed as well as high-quality manual
CPR. Based on their participation, Zoll officials determined HFD would
be a great partner in the advancement of the technology.
“The Houston Fire Department has a history of leading in emergency
medical advances in a way that has served our citizens well,” said Mayor
Parker. “Houstonians will benefit from a technology that has proven to
save lives and has great potential to save even more lives in the
future.”
Each year, Houston emergency personnel, with a staff of 3800 EMS trained
firefighters, treat an average of 1800 victims of SCA, the world’s
leading cause of death, which strikes without warning. SCA is an abrupt
disruption of the heart’s function that causes a lack of blood flow to
vital organs. High-quality, uninterrupted chest compressions are vital
to maintaining blood-flow to the heart and brain. Currently, only about
5 percent of victims survive; 95 percent will die from SCA. Houston
benefits from an excellent EMS system with a survival rate that is at
least double that estimate.
“Our primary goal is to save as many lives as we can. This device can
potentially help us advance our efforts to resuscitate more victims from
cardiac arrest,” said Dr. Persse.
“The quality of work performed by Houston firefighters is truly
unsurpassed by any other large EMS provider system in the world. The
Houston Fire Department is a rare blend of a large service that not only
delivers a high level of care to its citizens, but has a history of
improving the level of care it gives through involvement with leading
edge research,” said ZOLL President Jonathan Rennert. “We envision a
future where ZOLL continues to collaborate with the Houston Fire
Department on new life-savings technologies.”
In addition to helping improve outcomes from SCA, the AutoPulse helps
keep rescuers safe and frees their hands for other life-saving tasks.
The clinical trial conducted in Houston also involved cities throughout
the U.S. and Europe. Final conclusions from the trial are pending.
About the Houston Fire Department
HFD is the fourth largest fire department in the United States and is
responsible for preserving life and property to a population of more
than 2 million in an area totaling 617 square miles. In 2011, the HFD
renewed its claim as the world's largest accredited fire department.
Over the last few years, HFD has evolved into a highly sophisticated
public safety rescue system that has saved hundreds of lives and reduced
the severity of countless injuries and illnesses. The Houston Fire
Department has a vision that guides the organization towards excellence.
That goal is achieved through deliberate planning, adaptability and the
courage to embrace challenges and opportunities.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices and
software solutions that help advance emergency care and save lives,
while increasing clinical and operational efficiencies. With products
for defibrillation and monitoring, circulation and CPR feedback, data
management, fluid resuscitation, and therapeutic temperature management,
ZOLL provides a comprehensive set of technologies that help clinicians,
EMS and fire professionals, and lay rescuers treat victims needing
resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company
in 2007, 2008, and 2009, ZOLL develops and manufactures its products in
the United States, in California, Colorado, Illinois, Massachusetts,
Pennsylvania, and Rhode Island. More than 400 direct sales and service
representatives, 1,100 business partners, and 200 independent
representatives serve our customers in over 140 countries around the
globe. For more information, visit
www.zoll.com.
Copyright © 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill
Road, Chelmsford, MA 01824-4105. AutoPulse and ZOLL are trademarks or
registered trademarks of ZOLL Medical Corporation in the United States
and/or other countries. All trademarks are the property of their
respective owners.
